Skip to content

Clinical trials

Glucose Intolerance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Country / region: United States Clear all

348 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20036
20046
20058
200612
200713
20088
200916
20109
201123
201213
20139
201415
20157
201620
201714
201821
201919
202013
202125
202223
202312
202418
202516
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed236
Recruiting33
Terminated23
Active, not recruiting20
Unknown status18
Withdrawn9
Not yet recruiting4
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clinical Nutrition Research Center, Illinois Institute of Technology8
Johns Hopkins University8
University of California, Los Angeles8
Yale University8
Mayo Clinic7
The University of Texas Health Science Center at San Antonio7
Stanford University6
Duke University5
Emory University5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance348
Obesity90
Diabetes Mellitus, Type 272
Diabetes Mellitus69
Insulin Resistance68
Prediabetic State46
Metabolic Syndrome42
Overweight31
Hypertension24
Hyperglycemia13

Trials

Showing 1 to 25 of 348. Each trial links to its page on Pharma Observatory.

248 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.